NDC 67544-225

Lovastatin

Lovastatin

Lovastatin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, Llc. The primary component is Lovastatin.

Product ID67544-225_0c57c932-2720-4ab0-8ae4-24983c75130b
NDC67544-225
Product TypeHuman Prescription Drug
Proprietary NameLovastatin
Generic NameLovastatin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2001-12-17
Marketing End Date2022-05-31
Marketing CategoryANDA / ANDA
Application NumberANDA075636
Labeler NameAphena Pharma Solutions - Tennessee, LLC
Substance NameLOVASTATIN
Active Ingredient Strength40 mg/1
Pharm ClassesHMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC Exclude FlagN

Packaging

NDC 67544-225-15

15 TABLET in 1 BOTTLE, PLASTIC (67544-225-15)
Marketing Start Date2016-11-10
Marketing End Date2022-05-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 67544-225-45 [67544022545]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075636
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-10-25
Marketing End Date2022-05-31

NDC 67544-225-53 [67544022553]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075636
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-10-25
Marketing End Date2022-05-31

NDC 67544-225-80 [67544022580]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075636
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-09-16
Marketing End Date2022-05-31

NDC 67544-225-60 [67544022560]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075636
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-08-24
Marketing End Date2022-05-31

NDC 67544-225-30 [67544022530]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075636
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-09-22
Marketing End Date2022-05-31

NDC 67544-225-15 [67544022515]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075636
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-11-10
Marketing End Date2022-05-31

Drug Details

Pharmacological Class

  • HMG-CoA Reductase Inhibitor [EPC]
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

NDC Crossover Matching brand name "Lovastatin" or generic name "Lovastatin"

NDCBrand NameGeneric Name
0093-0576LovastatinLovastatin
0093-0926LovastatinLovastatin
0093-0928LovastatinLovastatin
0185-0070LovastatinLovastatin
0185-0072LovastatinLovastatin
0185-0074LovastatinLovastatin
0440-6694LovastatinLovastatin
0615-5589LovastatinLovastatin
0615-6551LovastatinLovastatin
0615-6590LovastatinLovastatin
0615-7674LovastatinLovastatin
0615-7679LovastatinLovastatin
0615-7685LovastatinLovastatin
0615-7690LovastatinLovastatin
0615-8151Lovastatinlovastatin
0615-8152Lovastatinlovastatin
10544-235LovastatinLovastatin
10544-241LovastatinLovastatin
10544-242LovastatinLovastatin
10544-246LovastatinLovastatin
21695-534LovastatinLovastatin
21695-535LovastatinLovastatin
21695-536LovastatinLovastatin
33261-547LovastatinLovastatin
33261-548LovastatinLovastatin
33261-549LovastatinLovastatin
35356-885LovastatinLovastatin
42254-025LovastatinLovastatin
42254-028LovastatinLovastatin
42254-106LovastatinLovastatin
68001-224LovastatinLovastatin
68001-315LovastatinLovastatin
68001-316LovastatinLovastatin
68001-214LovastatinLovastatin
68001-314LovastatinLovastatin
68071-3108LovastatinLovastatin
68071-1973LovastatinLovastatin
68071-3127LovastatinLovastatin
68071-3261LovastatinLovastatin
68071-3397LovastatinLovastatin
68071-4271LovastatinLovastatin
68084-559LovastatinLovastatin
68180-468LovastatinLovastatin
68180-467LovastatinLovastatin
68180-469LovastatinLovastatin
68645-576LovastatinLovastatin
68645-566LovastatinLovastatin
68788-2634LovastatinLovastatin
68645-567LovastatinLovastatin
68788-0926LovastatinLovastatin
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.